(Q45345155)

13 December 2017

Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders (English)

1 reference

Theodorus H Van der Kwast

13 December 2017

object named as

Theodorus H van der Kwast

7

0 references

author name string

Bas W G van Rhijn

1

1 reference

13 December 2017

Angela A G van Tilborg

2

1 reference

13 December 2017

Irene Lurkin

3

1 reference

13 December 2017

Jacky Bonaventure

4

1 reference

13 December 2017

Annie de Vries

5

1 reference

13 December 2017

Jean-Paul Thiery

6

1 reference

13 December 2017

Ellen C Zwarthoff

8

1 reference

13 December 2017

Francois Radvanyi

9

1 reference

13 December 2017

1 December 2002

1 reference

European Journal of Human Genetics

13 December 2017

1 reference

13 December 2017

10

1 reference

13 December 2017

819-824

1 reference

13 December 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ejhg.5200883

13 December 2017

0 references

cites work

RTK mutations and human syndromeswhen good receptors turn bad.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

FGFR activation in skeletal disorders: too much of a good thing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Distinct missense mutations of the FGFR3 lys650 codon modulate receptor kinase activation and the severity of the skeletal dysplasia phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Somatic mutations of fibroblast growth factor receptor 3 (FGFR3) are uncommon in carcinomas of the uterine cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial bladder carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

inferred from DOI database lookup

7 January 2021

based on heuristic

Hereditary retinoblastoma and risk of lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

inferred from DOI database lookup

7 January 2021

based on heuristic

A novel mutation in FGFR-3 disrupts a putative N-glycosylation site and results in hypochondroplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5200883

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.EJHG.5200883

1 reference

Dimensions Publication ID

13 December 2017

0 references

1 reference